Medications are available to treat many mental disorders, but they’re only effective if patients adhere to the treatment. A distribution agreement between Beckman Coulter Inc. and Saladax Biomedical Inc. aims to improve patient outcomes by providing health care professionals with tests to assess treatment compliance and individual patient drug response.

As interest in digital health increases and pandemic efforts decline, both med-tech deals and mergers and acquisitions this year continue to climb.

Sophia Genetics SA and Realm Idx Inc. established a collaboration for co-development of new genomic applications and their commercialization. The companies hope to expand next-generation sequencing research and multimodal data streams to improve cancer diagnostics and treatment outcomes.

Oculogica Inc. has signed an agreement with Minnetronix Inc. to launch a diagnostic device that tracks eye movements to detect possible brain concussion, this after receiving FDA clearance in December for its fourth iteration of the artificial intelligence-driven, battery-operated Eyebox.

Google Health is expanding the reach of its Care Studio technology to clinical software company Medical Information Technology Inc. (Meditech). The companies reported a partnership at HIMSS 2022 to integrate search functionalities from the Google product suite within Westwood, Mass.-based Meditech's web-based Expanse electronic health record (EHR). The aim is to combine data from different sources into a standard format and offer clinicians a full ‘holistic’ view of patient records.

Interrad Medical Inc. has formed a strategic partnership with Eloquest Healthcare Inc. to accelerate sales growth of what is described as the only subcutaneous catheter securement device in the world.

The FDA has cleared a plasma collection device developed by Terumo Blood and Cell Technologies (Terumo BCT) and plasma collection network CSL Plasma. The companies, which are subsidiaries of Terumo Corp. and CSL Ltd., signed a collaboration deal in 2021 to develop the new Rika device for CSL Plasma collection centers. The automated technology is designed to reduce plasma collection time to 35 minutes or less. According to the Red Cross, plasma donations currently take on average about 1 hour and 15 minutes.

Brightinsight Inc. and UCB SA struck a deal to jointly develop a digital disease management solution for patients with rare diseases. The companies will start with a mobile app for myasthenia gravis (MG) built on Brightinsight’s platform. UCB joins CSL Behring, Novo Nordisk A/S, Sanofi SA and Roche AG in partnering with Brightinsight on digital disease management.

Lumithera Inc. has completed the acquisition of Diopsys Inc. to expand its footprint of ocular disease care. Under the terms of the agreement, Pine Brook, N.J.-based Diopsys is now a wholly owned subsidiary of Poulsbo, Wash.-based Lumithera, with its electroretinography technology adding to Lumithera’s photobiomodulation (PBM) Valeda light delivery system for dry age-related macular degeneration (AMD) treatment.

The news from Quanterix Corp. has come fast and furiously this week. The company reported that Chairman and CEO Kevin Hrusovsky will step down on April 25 and become executive chairman of the board, while current company President Masoud Toloue will assume the CEO position and join the board of directors. Hrusovsky became CEO in 2014 and Toloue joined Quanterix in June 2021 from Perkinelmer Inc. The company also revealed that it has built on its collaboration with Indianapolis-based Eli Lilly and Co. for new tools to diagnose, monitor and treat Alzheimer’s disease (AD) and presented its fiscal 2021 financial results, which showed a 28% increase in total revenue, largely attributable to its neurology segment.